Senores Pharmaceuticals Limited has scheduled a meeting of its Board of Directors for Thursday, October 29, 2026. The primary agenda items for this meeting include:
- Consider and approve the Un-audited Consolidated and Standalone Financial Results of the Company for the quarter and half year ended September 30, 2026
- Transact other business matters
Trading Window Closure
In connection with the board meeting and results announcement, the Company refers to its earlier intimation dated September 24, 2026. Pursuant to the Company's Code of Conduct framed under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended, the Trading Window for dealing in securities of the Company remains closed from October 01, 2026. The closure will continue until 48 hours after the Un-audited Consolidated and Standalone Financial Results for the quarter and half year ended September 30, 2026 are approved by the Board of Directors and submitted to the Stock Exchanges.